Mechanistic studies on the high pressure neurological syndrome
- 7 January 1984
- journal article
- research article
- Published by The Royal Society in Philosophical Transactions of the Royal Society of London. B, Biological Sciences
- Vol. 304 (1118) , 31-41
- https://doi.org/10.1098/rstb.1984.0006
Abstract
The high pressure neurological syndrome (h.p.n.s.) constitutes a major barrier to deep sea exploration by man. Although the signs and symptoms of h.p.n.s. are well documented in both man and experimental animals, the underlying mechanisms remain to be elucidated. Physiological and pharmacological evidence will be presented that confirms that the principal sites of action of pressure are within the central nervous system (c.n.s.). Results from physiological studies not only indicate that there are separate sites of action of pressure within the c.n.s., which mediate the different components of h.p.n.s., but also the response to pressure may be controlled by descending inhibitory pathways. Pharmacological studies support this view and suggest that h.p.n.s. involves a failure of central inhibition.This publication has 12 references indexed in Scilit:
- The benzodiazepine antagonist, Ro 15-1788, prevents the effects of flurazepam on the high pressure neurological syndromeNeuropharmacology, 1982
- DRUGS THAT INCREASE γ-AMINOBUTYRIC ACID TRANSMISSION PROTECT AGAINST THE HIGH PRESSURE NEUROLOGICAL SYNDROMEBritish Journal of Pharmacology, 1982
- Brain monoamines and the high pressure neurological syndromeNeuropharmacology, 1980
- Diazepam Under Hyperbaric Conditions in RatsActa Anaesthesiologica Scandinavica, 1980
- Chemical Neurotoxins as Denervation Tools in NeurobiologyAnnual Review of Neuroscience, 1980
- Catecholamines and convulsionsBrain Research, 1979
- ALTERNATIVE APPROACHES TO ANALGESIA: BACLOFEN AS A MODEL COMPOUNDBritish Journal of Pharmacology, 1975
- Presynaptic Inhibition in the Spinal CordPublished by Elsevier ,1964
- Some neuropharmacologic effects of four mephenesin-like agents in miceToxicology and Applied Pharmacology, 1960
- THE MODE OF ACTION OF MYANESINBritish Journal of Pharmacology and Chemotherapy, 1947